Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA566570
Max Phase: Preclinical
Molecular Formula: C26H22BrIN4O2
Molecular Weight: 629.30
Molecule Type: Small molecule
Associated Items:
ID: ALA566570
Max Phase: Preclinical
Molecular Formula: C26H22BrIN4O2
Molecular Weight: 629.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C/C(=N\Nc1ccc([125I])cn1)c1ccc2c(c1)[C@@H]1C=CC[C@@H]1[C@H](c1cc3c(cc1Br)OCO3)N2
Standard InChI: InChI=1S/C26H22BrIN4O2/c1-14(31-32-25-8-6-16(28)12-29-25)15-5-7-22-19(9-15)17-3-2-4-18(17)26(30-22)20-10-23-24(11-21(20)27)34-13-33-23/h2-3,5-12,17-18,26,30H,4,13H2,1H3,(H,29,32)/b31-14+/t17-,18+,26-/m1/s1/i28-2
Standard InChI Key: ZADIWYPHRKHAFC-ZNXJKJKRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 629.30 | Molecular Weight (Monoisotopic): 627.9971 | AlogP: 6.84 | #Rotatable Bonds: 4 |
Polar Surface Area: 67.77 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 5.19 | CX LogP: 6.36 | CX LogD: 6.35 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.14 | Np Likeness Score: -0.91 |
1. Ramesh C, Nayak TK, Burai R, Dennis MK, Hathaway HJ, Sklar LA, Prossnitz ER, Arterburn JB.. (2010) Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30., 53 (3): [PMID:20041667] [10.1021/jm9011802] |
Source(1):